Searching the Resource Information Network

Our searching services are busy right now. Please try again later

  • Register
X
Forgot Password

If you have forgotten your password you can enter your email here and get a temporary password sent to your email.

X

Leaving Community

Are you sure you want to leave this community? Leaving the community will revoke any permissions you have been granted in this community.

No
Yes

Effect of AZD0530 on Cerebral Metabolic Decline in Alzheimer Disease: A Randomized Clinical Trial.

Christopher H van Dyck | Haakon B Nygaard | Kewei Chen | Michael C Donohue | Rema Raman | Robert A Rissman | James B Brewer | Robert A Koeppe | Tiffany W Chow | Michael S Rafii | Devon Gessert | Jiyoon Choi | R Scott Turner | Jeffrey A Kaye | Seth A Gale | Eric M Reiman | Paul S Aisen | Stephen M Strittmatter
JAMA neurology | 2019

Oligomeric amyloid-β peptide binds to cellular prion protein on the neuronal cell surface, activating intracellular fyn kinase to mediate synaptotoxicity and tauopathy. AZD0530 is an investigational kinase inhibitor specific for the Src family, including fyn, that has been repurposed for the treatment of Alzheimer disease.

Pubmed ID: 31329216

Research resources used in this publication

None found

Additional research tools detected in this publication

Antibodies used in this publication

None found

Associated grants

  • Agency: NCATS NIH HHS, United States
    Id: UL1 TR001863
  • Agency: NCATS NIH HHS, United States
    Id: UL1 TR002001
  • Agency: NIA NIH HHS, United States
    Id: P30 AG066508
  • Agency: NIA NIH HHS, United States
    Id: P50 AG047270
  • Agency: NCATS NIH HHS, United States
    Id: UH3 TR000967
  • Agency: NIA NIH HHS, United States
    Id: R01 AG034924
  • Agency: NIA NIH HHS, United States
    Id: RF1 AG053000

Publication data is provided by the National Library of Medicine ® and PubMed ®. Data is retrieved from PubMed ® on a weekly schedule. For terms and conditions see the National Library of Medicine Terms and Conditions.

This is a list of tools and resources that we have found mentioned in this publication.


Geriatric Depression Scale (tool)

RRID:SCR_008739

A basic screening measure for depression in older adults. They have a FREE iPhone APP and a FREE ANDROID APP that allows you to do the 15-item GDS on your phone and automatically calculate the results. They provide no interpretation of results, but patients with scores higher than 5 should be interviewed carefully. These apps are also available through the Android Marketplace or iTunes stores on your phones. Note: This page is under continuous development but they will try to keep translations of the scale available. Anyone with their own translation can submit it and they''ll post it.

View all literature mentions